Table 3

Comparative analysis between genotype frequencies and the risk of lung cancer in the subgroups of females
Female
 Genotype
 Cases
(n = 104)
 Controls
(n = 105)
 OR (95% CI)
 p-value
 asOR (95% CI)a
 p-value
-3444 C>T
 CC
 35
 39
 1
1

CT
 50
 58
 0.96 (0.53 – 1.74)
 0.89
 0.94 (0.51 – 1.72)
 0.85

TT
 19
 8
 2.65 (1.03 – 6.80)
 0.04
 2.23 (0.85 – 5.84)
 0.10

CT+TT
 69
 66
 1.17 (0.66 – 2.06)
 0.60
 1.11 (0.62 – 1.98)
 0.73


CC+CT
 85
 97
 1
1

TT
 19
 8
 2.71 (1.13 – 6.51)
 0.03
 2.31 (0.95 – 5.64)
 0.07
-1985 G>T
 GG
 36
 39
 1
1

GT
 49
 57
 0.93 (0.52 – 1.68)
 0.81
 0.93 (0.51 – 1.70)
 0.81

TT
 19
 9
 2.29 (0.92 – 5.70)
 0.08
 1.93 (0.76 – 4.91)
 0.17

GT+TT
 68
 66
 1.12 (0.63 – 1.97)
 0.70
 1.07 (0.60 – 1.92)
 0.81


GG+GT
 85
 96
 1
1

TT
 19
 9
 2.38 (1.02 – 5.55)
 0.04
 2.02 (0.85 – 4.78)
 0.11
P1170A C>G
 CC
 37
 37
 1
1

CG
 49
 58
 0.85 (0.47 – 1.53)
 0.58
 0.84 (0.46 – 1.55)
 0.59

GG
 18
 10
 1.80 (0.73 – 4.42)
 0.20
 1.57 (0.63 – 3.91)
 0.34

CG+GG
 67
 68
 0.99 (0.56 – 1.74)
 0.96
 0.96 (0.53 – 1.72)
 0.88


CC+CG
 86
 95
 1
1

GG
 18
 10
 1.99 (0.87 – 4.54)
 0.10
 1.73 (0.75 – 4.02)
 0.20

OR, odds ratio; CI, confidence interval.

aasOR are adjusted for age.

Jo et al. BMC Cancer 2008 8:359   doi:10.1186/1471-2407-8-359